Search research articles
Contact Us
Filters
Showing results (41-50 of 91) with videos related to
Page
of 10
Sort By:
Journal of Medicinal Chemistry
|
March 4, 2014
Differences in conformational dynamics between Plasmodium falciparum and human Hsp90 orthologues enable the structure-based discovery of pathogen-selective inhibitors
Tai Wang, William H Bisson, Pascal Mäser, et al.
Plos One
|
October 25, 2011
An interaction network predicted from public data as a discovery tool: application to the Hsp90 molecular chaperone machine
Pablo C Echeverría, Andreas Bernthaler, Pierre Dupuis, et al.
Cellular and Molecular Life Sciences : CMLS
|
March 3, 2023
Network-informed discovery of multidrug combinations for ERα+/HER2-/PI3Kα-mutant breast cancer
Dina Hany, Marloes Zoetemelk, Kaushik Bhattacharya, et al.
Molecular Cell
|
October 4, 2016
Monoubiquitination of Histone H2B Blocks Eviction of Histone Variant H2A.Z from Inducible Enhancers
Gregory Segala, Marcela A Bennesch, Deo Prakash Pandey, et al.
Biodata Mining
|
June 16, 2011
Detection of changes in gene regulatory patterns, elicited by perturbations of the Hsp90 molecular chaperone complex, by visualizing multiple experiments with an animation
Pablo C Echeverría, Fedor Forafonov, Deo P Pandey, et al.
The EMBO Journal
|
January 30, 2004
The protein kinase PKR: a molecular clock that sequentially activates survival and death programs
Olivier Donzé, Jing Deng, Joseph Curran, et al.
Oncotarget
|
June 10, 2017
A genetic polymorphism repurposes the G-protein coupled and membrane-associated estrogen receptor GPER to a transcription factor-like molecule promoting paracrine signaling between stroma and breast carcinoma cells
Marco Pupo, Alexandre Bodmer, Melissa Berto, et al.
Plos One
|
December 7, 2013
Dynamic impacts of the inhibition of the molecular chaperone Hsp90 on the T-cell proteome have implications for anti-cancer therapy
Ivo Fierro-Monti, Pablo Echeverria, Julien Racle, et al.
The EMBO Journal
|
January 21, 2009
Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF
Deo Prakash Pandey, Rosamaria Lappano, Lidia Albanito, et al.
Cell Stress & Chaperones
|
February 3, 2018
Methods to validate Hsp90 inhibitor specificity, to identify off-target effects, and to rethink approaches for further clinical development
Len Neckers, Brian Blagg, Timothy Haystead, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 91) with videos related to
Sort By:
Page
of 10
Journal of Medicinal Chemistry
|
March 4, 2014
Differences in conformational dynamics between Plasmodium falciparum and human Hsp90 orthologues enable the structure-based discovery of pathogen-selective inhibitors
Tai Wang, William H Bisson, Pascal Mäser, et al.
Plos One
|
October 25, 2011
An interaction network predicted from public data as a discovery tool: application to the Hsp90 molecular chaperone machine
Pablo C Echeverría, Andreas Bernthaler, Pierre Dupuis, et al.
Cellular and Molecular Life Sciences : CMLS
|
March 3, 2023
Network-informed discovery of multidrug combinations for ERα+/HER2-/PI3Kα-mutant breast cancer
Dina Hany, Marloes Zoetemelk, Kaushik Bhattacharya, et al.
Molecular Cell
|
October 4, 2016
Monoubiquitination of Histone H2B Blocks Eviction of Histone Variant H2A.Z from Inducible Enhancers
Gregory Segala, Marcela A Bennesch, Deo Prakash Pandey, et al.
Biodata Mining
|
June 16, 2011
Detection of changes in gene regulatory patterns, elicited by perturbations of the Hsp90 molecular chaperone complex, by visualizing multiple experiments with an animation
Pablo C Echeverría, Fedor Forafonov, Deo P Pandey, et al.
The EMBO Journal
|
January 30, 2004
The protein kinase PKR: a molecular clock that sequentially activates survival and death programs
Olivier Donzé, Jing Deng, Joseph Curran, et al.
Oncotarget
|
June 10, 2017
A genetic polymorphism repurposes the G-protein coupled and membrane-associated estrogen receptor GPER to a transcription factor-like molecule promoting paracrine signaling between stroma and breast carcinoma cells
Marco Pupo, Alexandre Bodmer, Melissa Berto, et al.
Plos One
|
December 7, 2013
Dynamic impacts of the inhibition of the molecular chaperone Hsp90 on the T-cell proteome have implications for anti-cancer therapy
Ivo Fierro-Monti, Pablo Echeverria, Julien Racle, et al.
The EMBO Journal
|
January 21, 2009
Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF
Deo Prakash Pandey, Rosamaria Lappano, Lidia Albanito, et al.
Cell Stress & Chaperones
|
February 3, 2018
Methods to validate Hsp90 inhibitor specificity, to identify off-target effects, and to rethink approaches for further clinical development
Len Neckers, Brian Blagg, Timothy Haystead, et al.
Page
of 10